Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Neoplasms and ELN[original query] |
|---|
| Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Dec 30 (36): 4515-23. Mrózek Krzysztof, Marcucci Guido, Nicolet Deedra, Maharry Kati S, Becker Heiko, Whitman Susan P, Metzeler Klaus H, Schwind Sebastian, Wu Yue-Zhong, Kohlschmidt Jessica, Pettenati Mark J, Heerema Nyla A, Block AnneMarie W, Patil Shivanand R, Baer Maria R, Kolitz Jonathan E, Moore Joseph O, Carroll Andrew J, Stone Richard M, Larson Richard A, Bloomfield Clara |
| Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation. Journal of the National Comprehensive Cancer Network : JNCCN 2017 Jun 15 (6): 790-796. Hidalgo-López Juliana E, Kanagal-Shamanna Rashmi, Medeiros L Jeffrey, Estrov Zeev, Yin C Cameron, Verstovsek Srdan, Konoplev Sergej, Jorgensen Jeffrey L, Mohammad Mohammad M, Miranda Roberto N, Zhao Chong, Lee John, Zuo Zhuang, Bueso-Ramos Carlos |
| Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. Leukemia 2017 10 31 (10): 2029-2036. Wang M, Lindberg J, Klevebring D, Nilsson C, Mer A S, Rantalainen M, Lehmann S, Grönberg |
| Identification of Prognostic and Susceptibility Markers in Chronic Myeloid Leukemia Using Next Generation Sequencing. Ethiopian journal of health sciences 2018 7 28 (2): 135-146. Shokeen Yogender, Sharma Neeta Raj, Vats Abhishek, Taneja Vibha, Minhas Sachin, Jauhri Mayank, Sankaran Satish, Aggarwal Shy |
| Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes. Cancer 2018 12 125 (7): 1091-1100. Boddu Prajwal C, Kadia Tapan M, Garcia-Manero Guillermo, Cortes Jorge, Alfayez Mansour, Borthakur Gautam, Konopleva Marina, Jabbour Elias J, Daver Naval G, DiNardo Courtney D, Naqvi Kiran, Yilmaz Musa, Short Nicholas J, Pierce Sherry, Kantarjian Hagop M, Ravandi Farh |
| Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. Cancer management and research 2019 6 11 4129-4142. Huang Yan, Hu Juan, Lu Ting, Luo Yi, Shi Jimin, Wu Wenjun, Han Xiaoyan, Zheng Weiyan, He Jingsong, Cai Zhen, Wei Guoqing, Huang He, Sun J |
| Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged?<60 years. Leukemia 2020 May . Eisfeld Ann-Kathrin, Kohlschmidt Jessica, Mims Alice, Nicolet Deedra, Walker Christopher J, Blachly James S, Carroll Andrew J, Papaioannou Dimitrios, Kolitz Jonathan E, Powell Bayard E, Stone Richard M, de la Chapelle Albert, Byrd John C, Mrózek Krzysztof, Bloomfield Clara |
| Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A. Proceedings of the National Academy of Sciences of the United States of America 2020 10 117 (42): 26340-26346. Bill Marius, Mrózek Krzysztof, Kohlschmidt Jessica, Eisfeld Ann-Kathrin, Walker Christopher J, Nicolet Deedra, Papaioannou Dimitrios, Blachly James S, Orwick Shelley, Carroll Andrew J, Kolitz Jonathan E, Powell Bayard L, Stone Richard M, de la Chapelle Albert, Byrd John C, Bloomfield Clara |
| Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement. Journal of hematology & oncology 2021 7 14 (1): 107. Bill Marius, Mrózek Krzysztof, Giacopelli Brian, Kohlschmidt Jessica, Nicolet Deedra, Papaioannou Dimitrios, Eisfeld Ann-Kathrin, Kolitz Jonathan E, Powell Bayard L, Carroll Andrew J, Stone Richard M, Garzon Ramiro, Byrd John C, Bloomfield Clara D, Oakes Christopher |
| Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia. Cancer medicine 2022 11 . Calleja Anne, Loschi Michael, Bailly Laurent, Morisot Adeline, Marceau Alice, Mannone Lionel, Robert Guillaume, Auberger Patrick, Preudhomme Claude, Raynaud Sophie, Subtil Fabien, Sujobert Pierre, Cluzeau Thom |
| Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. Cancer reports (Hoboken, N.J.) 2022 11 e1746. Shultz Carl, Gates Christopher, Petros William, Ross Kelly, Veltri Laruen, Craig Michael, Wen Sijin, Primerano Donald A, Hazlehurst Lori, Denvir James, Sdrimas Konstantin |
| Survival prediction in acute myeloid leukemia using gene expression profiling. BMC medical informatics and decision making 2022 Mar 22 (1): 57. Lai Binbin, Lai Yanli, Zhang Yanli, Zhou Miao, OuYang Guifa |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. Blood advances 2023 5 . Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein-Peterson, Maria E Arcila, Aaron J Stonestrom, Andrew Dunbar, Sheng F Cai, Jacob L Glass, Mark B Geyer, Raajit K Rampal, Ellin Berman, Omar I Abdel-Wahab, Eytan M Stein, Martin S Tallman, Ross L Levine, Aaron D Goldberg, Elli Papaemmanuil, Yanming Zhang, Mikhail Roshal, Andriy Derkach, Wenbin Xi |
| Somatic exonic deletions in RUNX1 constitutes a novel recurrent genomic abnormality in acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Eriksson Anna, Engvall Marie, Mathot Lucy, Österroos Albin, Rippin Martin, Cavelier Lucia, Ladenvall Claes, Baliakas Panagiot |
| Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial. Nature cancer 2023 10 . Nora Liebers, Peter-Martin Bruch, Tobias Terzer, Miguel Hernandez-Hernandez, Nagarajan Paramasivam, Donnacha Fitzgerald, Heidi Altmann, Tobias Roider, Carolin Kolb, Mareike Knoll, Angela Lenze, Uwe Platzbecker, Christoph Röllig, Claudia Baldus, Hubert Serve, Martin Bornhäuser, Daniel Hübschmann, Carsten Müller-Tidow, Friedrich Stölzel, Wolfgang Huber, Axel Benner, Thorsten Zenz, Junyan Lu, Sascha Dietri |
| Treatment outcome and germline predictive factors of ropeginterferon alpha-2b in myeloproliferative neoplasm patients. Cancer medicine 2024 4 13 (7): e7166. Chih-Cheng Chen, Ming-Chung Kuo, Ying-Hsuan Wang, Sung-Nan Pei, Ming-Lih Huang, Chiu-Chen Chen, Cih-En Huang, Yi-Yang Chen, Lee-Yung Sh |
- Page last reviewed:Feb 1, 2024
- Content source: